| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011 | 6197 | 2011 |
| The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ... Journal of thoracic oncology 10 (9), 1243-1260, 2015 | 4985 | 2015 |
| Lung cancer: current therapies and new targeted treatments FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, ... The Lancet 389 (10066), 299-311, 2017 | 3171 | 2017 |
| Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non–small-cell lung cancer F Cappuzzo, FR Hirsch, E Rossi, S Bartolini, GL Ceresoli, L Bemis, ... Journal of the National Cancer Institute 97 (9), 643-655, 2005 | 1978 | 2005 |
| Epidermal growth factor receptor in non–small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis FR Hirsch, M Varella-Garcia, PA Bunn Jr, MV Di Maria, R Veve, ... Journal of clinical oncology 21 (20), 3798-3807, 2003 | 1802 | 2003 |
| Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American … NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ... Archives of pathology & laboratory medicine 142 (3), 321-346, 2018 | 1621 | 2018 |
| PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ... Journal of Thoracic Oncology 12 (2), 208-222, 2017 | 1340 | 2017 |
| PD-L1 as a biomarker of response to immune-checkpoint inhibitors DB Doroshow, S Bhalla, MB Beasley, LM Sholl, KM Kerr, S Gnjatic, ... Nature reviews Clinical oncology 18 (6), 345-362, 2021 | 1099 | 2021 |
| Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non–small-cell lung cancer FR Hirsch, M Varella-Garcia, PA Bunn Jr, WA Franklin, R Dziadziuszko, ... Journal of clinical oncology 24 (31), 5034-5042, 2006 | 928 | 2006 |
| Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer MD Hellmann, MK Callahan, MM Awad, E Calvo, PA Ascierto, A Atmaca, ... Cancer cell 33 (5), 853-861. e4, 2018 | 875 | 2018 |
| Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology FR Hirsch, WA Franklin, AF Gazdar, PA Bunn Jr Clinical Cancer Research 7 (1), 5-22, 2001 | 820 | 2001 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 798 | 2017 |
| A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer DL Rimm, G Han, JM Taube, SY Eunhee, JA Bridge, DB Flieder, R Homer, ... JAMA oncology 3 (8), 1051-1058, 2017 | 785 | 2017 |
| PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ... Journal of Thoracic Oncology 13 (9), 1302-1311, 2018 | 752 | 2018 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 698 | 2017 |
| Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas CH Chung, K Ely, L McGavran, M Varella-Garcia, J Parker, N Parker, ... Journal of clinical oncology 24 (25), 4170-4176, 2006 | 689 | 2006 |
| Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with … FR Hirsch, M Varella-Garcia, J McCoy, H West, AC Xavier, P Gumerlock, ... Journal of clinical oncology 23 (28), 6838-6845, 2005 | 673 | 2005 |
| Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018 | 627 | 2018 |
| Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines SE Witta, RM Gemmill, FR Hirsch, CD Coldren, K Hedman, L Ravdel, ... Cancer research 66 (2), 944-950, 2006 | 610 | 2006 |
| Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer JP Neijt, SA Engelholm, MK Tuxen, PG Sørensen, M Hansen, C Sessa, ... Journal of Clinical Oncology 18 (17), 3084-3092, 2000 | 605 | 2000 |